IL-15 as a potential target in leukemia - Université de Lorraine Access content directly
Journal Articles Blood and lymphatic cancer: targets and therapy Year : 2015

IL-15 as a potential target in leukemia


Leukemia, one of the most aggressive hematopoietic malignancies, is characterized by excessive proliferation, survival, and impaired differentiation of hematopoietic stem cells. Interleukin 15, a proinflammatory cytokine, induces proliferation and promotes cell survival of human T and B lymphocytes, as well as natural killer cells. However, it may also play a detrimental role in the onset of leukemia. This review provided an overview of the aberrant expression of Interleukin 15 and its role in the development and progression of this hematological malignancy. Also, we critically explored the potential therapeutic opportunities involved in targeting the disruption of interleukin-15 signaling as well as in interleukin-15-mediated enhancement of antitumor immunity.
Fichier principal
Vignette du fichier
BLCTT-78347-il-15-as-a-potential-target-in-leukemia_040915.pdf (783.77 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

hal-01464505 , version 1 (10-02-2017)



Yu Xiong, Danièle Bensoussan, Véronique Decot. IL-15 as a potential target in leukemia. Blood and lymphatic cancer: targets and therapy, 2015, 5, pp.55—63. ⟨10.2147/BLCTT.S78347⟩. ⟨hal-01464505⟩
53 View
151 Download



Gmail Facebook X LinkedIn More